no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen
|
Oscherwitz, Jon |
|
2015 |
33 |
20 |
p. 2342-2346 5 p. |
article |
2 |
A retrospective study of administration of vaccination for hepatitis B among newborn infants prior to hospital discharge at a midwestern tertiary care center
|
Myers, Helen I. |
|
2015 |
33 |
20 |
p. 2316-2321 6 p. |
article |
3 |
Bacillus subtilis spores as adjuvants for DNA vaccines
|
Aps, Luana R.M.M. |
|
2015 |
33 |
20 |
p. 2328-2334 7 p. |
article |
4 |
Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France
|
Ribadeau Dumas, Florence |
|
2015 |
33 |
20 |
p. 2367-2378 12 p. |
article |
5 |
Editorial Board/Aims and Scope
|
|
|
2015 |
33 |
20 |
p. IFC- 1 p. |
article |
6 |
Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study
|
Canfell, Karen |
|
2015 |
33 |
20 |
p. 2387-2394 8 p. |
article |
7 |
High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice
|
Zhang, Chao |
|
2015 |
33 |
20 |
p. 2335-2341 7 p. |
article |
8 |
HIV specific responses induced in nonhuman primates with ANRS HIV-Lipo-5 vaccine combined with rMVA-HIV prime or boost immunizations
|
Dereuddre-Bosquet, Nathalie |
|
2015 |
33 |
20 |
p. 2354-2359 6 p. |
article |
9 |
Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) administered concomitantly with a booster dose of a hexavalent vaccine in 12–23-month-old infants
|
Deichmann, Klaus A. |
|
2015 |
33 |
20 |
p. 2379-2386 8 p. |
article |
10 |
Influenza vaccination in children with neurologic or neurodevelopmental disorders
|
Smith, Michael |
|
2015 |
33 |
20 |
p. 2322-2327 6 p. |
article |
11 |
M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection
|
Tao, Wenqian |
|
2015 |
33 |
20 |
p. 2307-2315 9 p. |
article |
12 |
Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials
|
Jin, Xia |
|
2015 |
33 |
20 |
p. 2347-2353 7 p. |
article |
13 |
Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?
|
Michel, R. |
|
2015 |
33 |
20 |
p. 2301-2306 6 p. |
article |
14 |
Vaccination-challenge studies with a Port Chalmers/73 (H3N2)-based swine influenza virus vaccine: Reflections on vaccine strain updates and on the vaccine potency test
|
De Vleeschauwer, Annebel |
|
2015 |
33 |
20 |
p. 2360-2366 7 p. |
article |
15 |
Vaccine introduction in the Democratic People's Republic of Korea
|
Marks, Florian |
|
2015 |
33 |
20 |
p. 2297-2300 4 p. |
article |